AORT
Artivion, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$22.58Close
$1.1BMarket cap
$20.10 – $47.6352-week range
Nov 5, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 6 · weaker than 94% of stocks over 12 months
- Far from its high 53% below its 52-week high
- Earnings shrinking EPS −1039% year on year
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
53%
1wk
down 3.1%
price change
1mo
down 1.1%
price change
12-month return
down 51%
market up 11% ·
its own down 61%
F-score
7 / 9
Strong
Altman Z
2.42
Moderate risk
P/E
114.0×
price / earnings
PEG
—
P/E / EPS growth
P/B
2.5×
price / book
Earnings yield
up 2.7%
EBIT / enterprise value
Cheaper than
43%
of the market · around average
Revenue growth
up 14%
year on year
EPS growth
down 1039%
latest quarter
Sales growth
up 11%
latest quarter · -6 pts
ROE
up 3%
return on equity
Free cash margin
0%
$839,000 FCF
D/E
0.48
long-term debt / equity
Net debt / EBITDA
2.7×
Interest cover
—EBIT / interest
Piotroski tests
- short-term liquidity weakened
- issued more shares
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- gross margin widened
- assets working harder
Repair signals
- Long-term debt down 32% ($0.3B → $0.2B)
Trade setup
ATR%
4.5%
$1.01 a day · 2×ATR $20.57
RS
6 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
1.1×
vs 50-day average
Up/down volume
0.69
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 13.6% over the year, from 43m to 49m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+3% vs market2 sessions after results
Financials
- Gross 64%
- Net 2%
- Free cash 0%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $253.2M | $298.8M | $313.8M | $354.0M | $388.5M | $441.3M |
| Gross margin | 66% | 66% | 65% | 65% | 64% | 64% |
| Operating income | $2.4M | $8.1M | $6.2M | $5.7M | $38.9M | $33.7M |
| Net income | -$16.7M | -$14.8M | -$19.2M | -$30.7M | -$13.4M | $9.8M |
| Net margin | -7% | -5% | -6% | -9% | -3% | 2% |
| Earnings per share | -$0.44 | -$0.38 | -$0.48 | -$0.75 | -$0.32 | $0.21 |
| Free cash flow | $5.0M | -$15.7M | -$15.9M | $9.1M | $11.0M | $839,000 |
| Free cash margin | 2% | -5% | -5% | 3% | 3% | 0% |
| Cash | $61.4M | $55.0M | $39.4M | $58.9M | $53.5M | $64.9M |
| Long-term debt | $290.5M | $307.5M | $306.5M | $305.5M | $314.2M | $215.1M |
| Shareholders' equity | $328.7M | $300.7M | $284.3M | $281.8M | $276.2M | $448.2M |
| Shares outstanding | 40.39m | 41.40m | 41.83m | 42.57m | 43.43m | 49.33m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 7, 2026 | Quarterly ↗ | Jun 30, 2026 | 38d |
| May 8, 2026 | Quarterly ↗ | Mar 31, 2026 | 38d |
| Feb 18, 2026 | Annual ↗ | Dec 31, 2025 | 49d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
| May 6, 2025 | Quarterly ↗ | Mar 31, 2025 | 36d |
| Feb 28, 2025 | Annual ↗ | Dec 31, 2024 | 59d |
| Nov 8, 2024 | Quarterly ↗ | Sep 30, 2024 | 39d |
| Aug 9, 2024 | Quarterly ↗ | Jun 30, 2024 | 40d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 23, 2024 | Annual ↗ | Dec 31, 2023 | 54d |
| Nov 3, 2023 | Quarterly ↗ | Sep 30, 2023 | 34d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 6, 2026 | Results ↗ |
| May 18, 2026 | Regulation FD · Other events ↗ |
| May 15, 2026 | Shareholder vote ↗ |
| May 7, 2026 | Material agreement · Results ↗ |
| Feb 12, 2026 | Results ↗ |
| Nov 6, 2025 | Results ↗ |
| Sep 29, 2025 | Material agreement ↗ |
| Sep 15, 2025 | Material agreement · New obligation ↗ |
| Aug 11, 2025 | Director or officer change ↗ |
| Aug 7, 2025 | Results ↗ |
| May 29, 2025 | Unregistered share sale · Other events ↗ |
| May 16, 2025 | Shareholder vote ↗ |